Position in RXST
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$4,252,116
-$2,970,463 QoQ
Shares Held
690,279
-0.4% QoQ
Ownership
1.66%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BAILLIE GIFFORD & CO holds $1,506,293,012 across 7 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DXCM |
Dexcom Inc
|
14,801,590 | $996,887,084 | |
| 2 | PODD |
Insulet Corp
|
2,042,313 | $310,942,153 | |
| 3 | EW |
Edwards Lifesciences Corp
|
1,208,945 | $109,361,162 | |
| 4 | MDT |
Medtronic plc
|
463,954 | $36,295,119 | |
| 5 | PRCT |
PROCEPT BioRobotics Corp
|
911,751 | $20,587,335 | |
| 6 | TMDX |
TransMedics Group, Inc.
|
267,935 | $17,796,240 | |
| 7 | NVCR |
NovoCure Ltd
|
952,074 | $14,423,919 |
All Filings in RXST
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,252,116 | 690,279 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $7,222,579 | 693,146 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $6,169,979 | 686,316 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $6,096,285 | 468,945 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $9,903,831 | 392,231 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $13,714,422 | 398,907 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $20,711,366 | 419,004 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $21,553,795 | 358,215 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,429,140 | 66,482 | Shares | Sole | 2024-05-01 | |
| No filing history on record for this holder in this stock. | ||||||